Skip to main content

Gilead sues Teva over approval application for generic Truvada


NEW YORK Gilead Sciences has filed a lawsuit against Israeli generic drug maker Teva Pharmaceutical Industries and a subsidiary.

Gilead, which filed the suit Friday in a United States District Court in New York, alleged that Teva committed patent infringement when it filed an approval application with the Food and Drug Administration for a generic version of Truvada (emtricitabine), a drug for treating HIV.

Gilead has a license to manufacture and sell the drug from Emory University in Atlanta.

This ad will auto-close in 10 seconds